Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.400 | None | 0.969 | 0 | 0 | 1985 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.972 | 0 | 0 | 1987 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.400 | None | 0.974 | 0 | 0 | 2000 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.975 | 0 | 0 | 1992 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.400 | None | 0.976 | 0 | 0 | 1995 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1997 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1992 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1987 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1992 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.978 | 0 | 0 | 1989 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.978 | 0 | 0 | 1995 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 2003 | 2020 | ||||||||
|
BLM RecQ like helicase | 0.535 | 0.808 | 1.5E-15 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 1999 | 2019 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 2004 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 0.979 | 0 | 0 | 1984 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 2002 | 2020 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 2001 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 1995 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.984 | 0 | 0 | 1988 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.986 | 0 | 0 | 1999 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.400 | None | 0.987 | 0 | 0 | 1994 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.988 | 0 | 0 | 1997 | 2020 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1995 | 2019 |